Aktuelle News
News Funktionen
Weitere Funktionen
20 November 2017
PledPharma AB
PledPharma and Solasia enter license agreement to develop and commercialize PledOx(r) in Asia
26 Juni 2015
PledPharma AB
PLEDPHARMA PRESENTS ADDITIONAL RESULTS FROM A PHASE IIB STUDY WITH PLEDOX® AT THE SCIENTIFIC CONFERENCE MASCC
21 April 2015
PledPharma AB
Interim report first quarter 2015
29 März 2015
PledPharma AB
PLEDPHARMA PRESENTS TOP-LINE RESULTS FROM ITS PHASE IIb STUDY – PLEDOX(r) REDUCES NERVE DAMAGE IN CONJUNCTION WITH CHEMOTHERAPY BY 43 PERCENT
PledPharma AB
PLEDPHARMA PRESENTS TOP-LINE RESULTS FROM ITS PHASE IIb STUDY – PLEDOX® REDUCES NERVE DAMAGE IN CONJUNCTION WITH CHEMOTHERAPY BY 43 PERCENT
17 Februar 2015
PledPharma AB
Year-end report 2014
17 Dezember 2014
PledPharma AB
PledPharma’s rights issue oversubscribed by 34 percent
14 November 2014
PledPharma AB
More than 50 percent of the owners confirm subscription commitments in PledPharma’s planned rights issue
24 Oktober 2014
PledPharma AB
PledPharma AB – Interim report third quarter 2014
PledPharma AB
PledPharma presents a new project against acetaminophen-induced poisoning, aimed to be financed by a rights issue
21 Oktober 2014
PledPharma AB
The PLIANT study is fully recruited and the final futility analysis approved
12 September 2014
PledPharma AB
Information video about PLIANT study available
10 September 2014
PledPharma AB
PledPharma awarded Nordic Star of the Year
9 September 2014
PledPharma AB
The second futility analysis in the PLIANT study completed and approved
28 August 2014
PledPharma AB
PledPharma AB – Interim report second quarter 2014
26 August 2014
PledPharma AB
Positive data from an additional 5 patients in the first part of the PLIANT study
18 August 2014
PledPharma AB
Futility analysis in PLIANT study completed and approved by the DSMB
13 Mai 2014
PledPharma AB
Rights issue in PledPharma oversubscribed
25 April 2014
PledPharma AB
PledPharma AB (publ) Interim report first quarter 2014
23 April 2014
PledPharma AB
Go-ahead for PledPharma to also include Avastin patients in Part 2 of the PLIANT study
24 März 2014
PledPharma AB
PledPharma AB (publ) issues new shares
19 Februar 2014
PledPharma AB
Year end report 2013
18 Februar 2014
PledPharma AB
PledPharma brings forward publication date for full year report 2013
12 Februar 2014
PledPharma AB
Positive data from the first part of the PLIANT study
PledPharma AB
Positive data from the first part of the PLIANT study
10 Dezember 2013
PledPharma AB
First patient treated in part 2 of the PLIANT-study
18 November 2013
PledPharma AB
Nomination Committee for the 2014 Annual General Meeting in PledPharma AB
13 November 2013
PledPharma AB
Go-ahead for PledPharma to start part 2 of the PLIANT study
25 Oktober 2013
PledPharma AB
Interim Report Third Quarter 2013
15 Oktober 2013
PledPharma AB
The sixth patient in the first part of the PLIANT-study approved for continued dosing